lunes, 22 de junio de 2026

Rethinking The Value Of The 180-Day Exclusivity Period For Generic Drugs Keith M. Drake June 15, 2026

https://www.healthaffairs.org/content/forefront/rethinking-value-180-day-exclusivity-period-generic-drugs?utm_campaign=forefront&utm_medium=email&_hsenc=p2ANqtz-9A_8UkUhnYS_uOwQSGY2qDRPvb6eYJjEwE1KDYBm67QNNNIy_Cx_lG-T9qz5fbWNKOFLAOThvTUE-IN-lY2VZJrf0QoA&_hsmi=424329869&utm_source=hasu Given the high stakes involved, the generic exclusivity period’s effects on competition should be scrutinized.

No hay comentarios: